Rigel Pharmaceuticals Inc (RIGL)

Sales/Maturities of Investments

$92.78M

Quarterly · Period ending: · USD

RIGL logo

RIGL Sales/Maturities of Investments

Latest reported$92.78M
RIGL Quarterly Sales/Maturities of Investments ($3.97M → $92.78M)
High-resolution chart · PNG

RIGL sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
92,783,000
15,945,000
13,549,000
20,730,000
15,750,000
11,100,000
6,750,000
6,000,000
18,700,000
8,250,000
6,000,000
8,250,000
11,750,000
15,650,000
21,166,000
29,417,000
20,795,000
29,850,000
30,850,000
1,399,000
17,901,000
11,900,000
27,250,000
40,414,000
24,350,000
38,420,000
37,820,000
40,681,000
25,450,000
19,175,000
30,100,000
24,450,000
20,866,000
28,650,000
17,439,000
26,932,000
19,905,000
32,544,000
22,559,000
25,273,000
39,822,000
40,996,000
54,765,000
57,977,000
24,600,000
59,520,000
63,814,000
53,866,000
73,750,000
90,275,000
56,166,000
81,926,000
116,959,000
127,396,000
84,898,000
77,735,000
143,406,000
133,685,000
181,437,000
86,756,000
69,727,000
77,573,000
68,060,000
69,924,000
40,999,000
37,266,000
29,759,000
17,500,000
44,963,000
47,169,000
39,033,000
63,877,000
36,536,000
30,676,000
44,268,000
26,470,000
27,501,000
29,269,000
34,539,000
26,280,000
19,718,000
9,450,000
18,333,000
27,734,000
23,655,000
19,505,000
30,591,000
17,185,000
14,150,000
10,250,000
5,250,000
-7,000
0
0
250,000
28,264,000
12,450,000
6,875,000
11,350,000
14,275,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.